CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
tissue plasminogen activatordrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000468
NCT00000468Phase 3Completed
CompareCT.gov

Myocardial Infarction Triage and Intervention Project (MITI)

University of Washington·interventional·Posted Oct 28, 1999·Updated Feb 9, 2016

In Brief

A Phase 3 clinical trial evaluating tissue plasminogen activator for Cardiovascular Diseases and 4 related conditions. Completed.

Detailed Summary

To determine the practicality, benefit, and safety of paramedic administration of thrombolytic therapy for acute myocardial infarction. The feasibility of paramedics correctly identifying candidates for thrombolytic therapy following myocardial infarction was assessed in Phase I. In Phase II, pre-hospital thrombolytic therapy was compared with in-hospital thrombolytic therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Disease, Heart Diseases, Myocardial Infarction, Myocardial Ischemia
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 3CompletedFinished
1988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartApr 1, 1988
Study CompletionMar 1, 1992
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

tissue plasminogen activatordrug